ABOUT AES CLEAN TECHNOLOGY
We are the only USA based cleanroom company that self-performs design, manufacture, and installation of cGMP modular cleanroom facilities. Working with AES, you can rest assured that your project is built on time and on budget, guaranteed. Our expertise in cleanroom solutions combined with our focus on your project success is second to none.
Reducing Risks With Single-Sourced Modular Cleanrooms
Life sciences industries require highly controlled environments for drug research development and manufacturing.
Safety Department At Cleanroom Manufacturer Ensures No One Gets Hurt
AES takes the well-being and safety of all of our team members very seriously. In this video, AES director of EHS Tony Mangabat highlights some of the measures our safety department takes to ensure no one gets hurt at AES.
Cleanroom Manufacturer Expands Capacity To Meet Industry Needs
AES Clean Technology builds more cleanrooms than anyone else. The market is busy, and so are we... but are we too busy? The answer is a resounding "NO, AES is not too busy!" We plan our cleanroom design, panel manufacturing, and manpower loading and scale as needed. We currently have the capacity to more than double our panel manufacturing.
Modular Cleanroom Panel Manufacturing Factory Tour
AES Clean Technology Manufactures Modular Cleanroom Solutions. AES utilizes modular cleanroom systems in our design-builds and modular cleanroom construction projects. The AES cleanroom wall system is made in our state of the art Suwanee, GA facility.
AES Announces Sales Manager Opening For Western US Region
The Sales Manager has primary responsibility for AES business development activities within the Western Region.
The 7 Essentials For A Successful Cleanroom RFP
If you follow these 7 steps, you will receive better responses to your cleanroom RFP and be able to identify differences and minimize risk.
Best Practices For Cleanroom Project Delivery And Construction
Cleanroom Design, Manufacturing and Construction. AES provides complete cleanroom project delivery with guaranteed performance. Our integrated products + solutions offering provides risk mitigation with single source responsibility.
AES Clean Technology Announces Jose Jimenez As New VP Of Construction
AES Clean Technology, design-builder of modular cleanroom facility solutions, announced today that Jose Jimenez has been named as its Vice President of Construction.
Cleanroom Leader, AES Clean Technology, Opens New Office In Irvine CA
AES Clean Technology, a global leader in modular cleanroom manufacturing and rapid cleanroom design/build with headquarters in Montgomeryville, PA, announces the opening of a new office in Irvine, CA.
What Cleanroom Build Method Is Best For You?
Your future cleanroom is a critical asset, it is not just another construction project. The investment you make in the cleanroom facility is significant and it should perform for years to come. Learn the relative strengths and weaknesses of various cleanroom construction methodologies that are being implemented within the marketplace.
Custom Designed Clinical Manufacturing Cleanrooms For Penn Medicine’s Cell And Gene Therapy Operations
A GMP manufacturing suite was developed which included a custom-designed and constructed Clinical Manufacturing cleanroom core for producing PENN Medicine's cell and gene therapy candidates.
How To Implement Cleanroom Upgrades While Operating Your Facility
It goes without saying that upgrades during a manufacturing shutdown pose less risk as there are no products being produced, but there are instances when it is critical to expand capacity or modify functionality while maintaining some processing. Following are a steps to help maintain control of production and changes—and demonstrate proof of control—while keeping the involved workers and the products safe.
Facility Design Takeaways From Novartis And University Of Pennsylvania Cell Therapy Facility
In August the Novartis Institutes for Bio-Medical Research, based in Cambridge, Massachusetts, and the University of Pennsylvania’s Perelman School of Medicine (Penn Medicine) announced they had entered into an exclusive global research and licensing agreement. Under the alliance, Penn Medicine granted Novartis an exclusive worldwide license to the technologies used in an ongoing trial of patients with chronic lymphocytic leukemia (CLL) as well as future therapies based on chimeric antigen receptor (CAR) technology developed through the collaboration.